◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › ATEC

Alphatec Holdings Inc (ATEC) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-16

Alphatec Holdings Inc (ATEC) operates in the MEDICAL DEVICES industry and is headquartered in Carlsbad, United States with about 913 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ATEC reported $764M in revenue and ($143M) in net income.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.

Interactive charts & full statements → Open the ATEC valuation workbench →

ATEC Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$815M	$764M	$612M	$482M	$351M	$243M	$145M	$113M	$92M	$102M	$120M	$185M	$207M	$205M	$196M	$198M	$172M	$132M	$101M	$80M	$74M
Gross Profit	$539M	$532M	$424M	$310M	$233M	$158M	$103M	$78M	$63M	$62M	$76M	$122M	$145M	$126M	$126M	$117M	$113M	$84M	$65M	$50M	$48M
Gross Margin %	66.1%	69.6%	69.4%	64.3%	66.4%	64.9%	70.8%	68.4%	69.0%	61.3%	63.3%	65.6%	70.1%	61.6%	63.9%	59.1%	65.7%	63.7%	63.9%	62.7%	65.3%
Operating Income (EBIT)	($45M)	($82M)	($136M)	($173M)	($147M)	($128M)	($59M)	($47M)	($22M)	($9M)	($15M)	($172M)	$2M	($73M)	($10M)	($25M)	($12M)	($10M)	($28M)	($20M)	($22M)
Operating Margin %	-5.5%	-10.8%	-22.3%	-35.9%	-41.9%	-52.6%	-40.6%	-41.7%	-24.5%	-8.8%	-12.8%	-93.1%	0.9%	-35.9%	-5.0%	-12.4%	-6.9%	-7.2%	-27.5%	-24.6%	-29.9%
Net Income	($110M)	($143M)	($162M)	($187M)	($151M)	($143M)	($79M)	($57M)	($29M)	($2M)	($30M)	($179M)	($13M)	($82M)	($15M)	($22M)	($14M)	($13M)	($29M)	($20M)	($26M)
Net Margin %	-13.5%	-18.8%	-26.5%	-38.7%	-43.1%	-58.8%	-54.5%	-50.2%	-31.6%	-2.2%	-25.2%	-96.4%	-6.2%	-40.2%	-7.9%	-11.2%	-8.4%	-10.1%	-28.9%	-25.2%	-34.9%
EBITDA	$13M	($40M)	($54M)	($111M)	($103M)	($107M)	($55M)	($39M)	($13M)	$0M	($13M)	($149M)	$20M	($49M)	$10M	($4M)	$7M	$2M	($18M)	($8M)	($13M)
Earnings Per Share (EPS)	$-0.72	$-0.96	$-1.13	$-1.54	$-1.46	$-1.49	$-1.18	$-1.09	$-0.82	$-0.17	$-3.53	$-21.53	$-1.58	$-10.25	$-2.06	$-3.00	$-2.19	$-3.24	$-7.59	$-6.50	$-11.37
Shares Outstanding (M)	155M	150M	143M	121M	103M	96M	67M	52M	35M	13M	9M	8M	8M	8M	8M	7M	7M	4M	4M	3M	2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATEC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$214M	$192M	$213M	$197M	$186M	$169M	$177M	$151M
Gross Profit	$154M	$117M	$130M	$137M	$129M	$116M	$122M	$103M
Gross Margin %	72.2%	61.1%	61.2%	69.9%	69.6%	68.6%	68.8%	68.2%
Operating Income (EBIT)	($2M)	($22M)	($5M)	($16M)	($13M)	($44M)	($24M)	($34M)
Operating Margin %	-0.9%	-11.5%	-2.5%	-8.1%	-7.0%	-26.2%	-13.5%	-22.4%
Net Income	($26M)	($34M)	($22M)	($29M)	($41M)	($52M)	($33M)	($40M)
Net Margin %	-12.1%	-17.6%	-10.2%	-14.5%	-22.2%	-30.7%	-18.9%	-26.3%
EBITDA	$6M	($2M)	$4M	$5M	($8M)	($23M)	($4M)	($11M)
Earnings Per Share (EPS)	$-0.17	$-0.22	$-0.14	$-0.19	$-0.27	$-0.35	$-0.23	$-0.28
Shares Outstanding (M)	155M	154M	150M	151M	150M	147M	143M	143M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATEC Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$57M	$45M	($45M)	($78M)	($75M)	($73M)	($46M)	($33M)	($26M)	($9M)	($10M)	$10M	($20M)	$8M	$12M	$13M	($15M)	($6M)	($19M)	($13M)	($9M)
Capital Expenditures (CapEx)	$52M	$42M	$93M	$87M	$58M	$69M	$24M	$13M	$7M	$8M	$9M	$12M	$11M	$15M	$17M	$9M	$16M	$13M	$13M	$8M	$10M
Free Cash Flow (FCF)	$4M	$3M	($138M)	($165M)	($133M)	($142M)	($70M)	($46M)	($33M)	($16M)	($19M)	($2M)	($32M)	($7M)	($6M)	$5M	($31M)	($19M)	($33M)	($21M)	($18M)
FCF Margin %	0.5%	0.4%	-22.5%	-34.3%	-38.0%	-58.4%	-48.5%	-40.7%	-35.5%	-16.1%	-15.9%	-1.1%	-15.2%	-3.6%	-3.0%	2.3%	-18.2%	-14.2%	-32.4%	-26.5%	-24.7%
Dividends Paid	—	—	—	$1M	$3M	$316M	—	—	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATEC Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$21M	$1M	$21M	$14M	$16M	($5M)	$11M	($5M)
Capital Expenditures (CapEx)	$20M	$12M	$11M	$9M	$12M	$10M	$4M	$20M
Free Cash Flow (FCF)	$1M	($11M)	$10M	$5M	$3M	($15M)	$7M	($25M)
FCF Margin %	0.3%	-5.6%	4.5%	2.5%	1.8%	-8.8%	3.8%	-16.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATEC Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$791M	$791M	$776M	$805M	$521M	$572M	$261M	$170M	$129M	$85M	$94M	$147M	$345M	$366M	$382M	$367M	$377M	$162M	$156M	$147M	$129M
Cash & Cash Equivalents	$119M	$161M	$139M	$221M	$85M	$187M	$108M	$47M	$29M	$22M	$20M	$11M	$20M	$21M	$22M	$21M	$23M	$10M	$18M	$26M	$17M
Total Liabilities	$803M	$755M	$766M	$703M	$556M	$493M	$131M	$126M	$112M	$111M	$136M	$183M	$196M	$194M	$136M	$121M	$111M	$87M	$84M	$52M	$52M
Total Debt (Short + Long-Term)	$582M	$572M	$583M	$518M	$369M	$331M	$43M	$55M	$46M	$41M	$46M	$80M	$83M	$55M	$42M	$28M	$34M	$30M	$29M	$7M	$8M
Total Shareholders' Equity	($12M)	$36M	$9M	$102M	($35M)	$79M	$130M	$44M	$18M	($27M)	($42M)	($37M)	$149M	$172M	$246M	$245M	$266M	$75M	$71M	$95M	$75M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ATEC viewer.

Other Companies in MEDICAL DEVICES

UFPT · UFP Technologies Inc — $2 billion
BFLY · Butterfly Network Inc — $2 billion
ESTA · Establishment Labs Holdings Inc — $2 billion
NVCR · Novocure Ltd — $2 billion
CNMD · CONMED Corporation — $1 billion
IART · Integra LifeSciences Holdings — $1 billion
TNDM · Tandem Diabetes Care Inc — $1 billion
AORT · Artivion Inc — $1 billion

← ATEA All “A” companies ATEME →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.